REG - TruFin PLC TruFin PLC - Trading Statement

TrufinAnnouncement

06/01/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250106:nRSF1636Sa&default-theme=true

RNS Number : 1636S  TruFin PLC  06 January 2025

6 January 2025

 

TruFin plc

("TruFin" or the "Group")

 

Trading Update

 

TruFin is pleased to announce that it expects its adjusted profit before
tax(1) ("PBT") to be significantly ahead of market expectations resulting in
its first full year profit - a year earlier than forecast. For the 12 months
ended 31 December 2024, PBT is now expected to be more than £0.5m (FY23:
£(6.6)m) with adjusted EBITDA(1) also expected to be significantly ahead of
prior expectations at more than £7.0m, representing a year-on-year
improvement in excess of £10m (FY23: £(3.5)m).

 

Group revenue is expected to be approximately £54.0m. This represents growth
in excess of 197% (FY23: £18.1m).

 

The significantly better than expected financial performance has been driven
by exceptional year-end performances from Balatro and Abiotic Factor - two of
Playstack Limited's ("Playstack") games launched during 2024. Balatro's recent
award wins in three categories at the Game Awards: 'Best Independent Game',
'Best Mobile Game' and 'Best Debut Indie Game', helped to significantly boost
sales of the game during December.

 

Oxygen Finance Group Limited ("Oxygen") grew revenues with metronomic
consistency in 2024, resulting in growth of 21% to no less than £7.5m (FY23:
£6.2m).  EBITDA grew 65% at no less than £2.1m (FY23: £1.3m). With four
new Early Payment ("EP") client wins during 2024 and all four EP clients up
for renewal during 2024 contracting for further five year terms, Oxygen ended
the year with a record 62 EP clients.

 

Satago Financial Solutions Limited ("Satago") aggressively realigned its cost
base during 2024 and is in advanced talks with several Tier-1 Banks and other
potential clients. Having lost its contract with a Tier-1 Bank in July 2024,
revenues for 2024 are expected to be no less than £2.4m (FY23: £3.8m). Loss
before tax is expected to be no more than £(4.9)m (FY23: £(4.2)m). Satago
has a fully costed and funded plan to achieve cash flow breakeven in the next
18 months.

 

Cash at year end is no less than £14.0m, of which unrestricted cash is no
less than £12.5m. The Group has had an exceptional year and remains focused
on realising value for shareholders.

 

James van den Bergh, Chief Executive Officer, commented:

 

"What a year for the Group. A year of many firsts.

This is the first time we have grown revenues by more than 190%. It is the
first year we have recorded an EBITDA profit and the first year we have
achieved a profit before tax - a year ahead of schedule.

Most importantly our newly minted profitability status is not a one off.
Although we expect 2025 to be a year of consolidation, we will maintain our
disciplined approach to allocating internal resources and expect the Group to
grow all the profitability lines in 2025 and beyond.

After years of considered investment and planning, Playstack has come of age.
The standout financial achievements this year are the remarkable revenue
growth of over 440% with an exceptional EBITDA growth of over 2,000%.

These achievements would not have been possible without our extremely
disciplined and careful approach to building a robust and scalable games
publisher.

The success of Balatro should not be underestimated and it has been a joy to
watch it build throughout the year. However, it is important to also praise
the team for the exceptional performances of Abiotic Factor and The Rise of
the Golden Idol. Success breeds success and with eight game releases due in
2025 and a growing pipeline of game releases for 2026, we are closer than ever
to monetising shareholder value from Playstack.

Following Vicki Sloane's appointment as Chief Executive Officer of Oxygen it
is very pleasing to see her team deliver new highs across the board. Notably,
this is the first year that shareholders have enjoyed the benefits of Oxygen's
inherent operational gearing. With more than 82% of the next five years' Early
Payment revenues already contracted, shareholders have much to look forward
to.

Satago's loss of a Tier-1 Bank contract in July 2024 was an enormous shock.
However, the team have realigned the cost base and are poised for a year of
growth, with a clear business plan to achieve cash breakeven within 18 months.
We are focused on rebuilding shareholder value and the recent share
recapitalisation at Satago is the first step to achieving that.

I look forward to providing a more detailed update during TruFin's annual
results statement. In the meantime, I would like to again thank our
shareholders for their ongoing support. This has been an exceptional year, and
it is safe to say the Group has never been better positioned to deliver
further shareholder value."

Notes

(1) profit or loss adjusted to remove share-based payment charges

 

 

The information contained within this Announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulation
(EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit)
Regulations 2019. By the publication of this Announcement via a Regulatory
Information Service, this inside information is now considered to be in the
public domain. The person responsible for arranging for the release of this
Announcement on behalf of the Company is Pav Subramaniam.

For further information, please contact:

 TruFin plc                                                        0203 743 1340

James van den Bergh, Chief Executive Officer
07779 229508

Kam Bansil, Investor Relations
 Liberum Capital Limited (Nominated Adviser and Corporate broker)

Chris Clarke

Edward Thomas                                                    0203 100 2000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTDZGGMGKZGKZZ